AVEA
The longevity supplement start-up with the aim to improve health-span
Total raised
€4.7M
€4,724,515
Funding rounds
2
Investors
3
distinct backers
Active since
2022-06
latest 2023-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood35
base rate 44% for Seed
- ▼ Overdue vs cohort gap
Exit likelihood12
base rate 12% (2+ rounds)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-04 | Seed | €2.3M | Maximon | View deal → |
| 2022-06-01 | Other | €2.4M | Longevity Co-Investment Fund,Maximon,The Longevity Company Builder | View deal → |
Related news
- Swiss longevity startup Avea gets €2.43 million boostertech.eu · 2022-06
- CHF2.5 million to support the growth of longevity start-up AVEAstartupticker.ch · 2022-06
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy